Biotechnology AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall – Cerevel Therapeutics Hldg (NASDAQ:CERE), AbbVie (NYSE:ABBV) Read more
Opinion Thinking about buying stock in Alibaba Group, Akebia Therapeutics, Plug Power, AMC Entertainment, or C4 Therapeutics? – Akebia Therapeutics (NASDAQ:AKBA), AMC Enter Hldgs (NYSE:AMC) Read more
Biotechnology First Patient Dosed In Phase 2 Study Of Elicio Therapeutics’ ELI-002 7P – Elicio Therapeutics (NASDAQ:ELTX) Read more
Biotechnology Jnana Therapeutics Announces Positive Clinical Proof of Concept Achieved with JNT-517, a Potential First-in-Class Oral Treatment for PKU Read more
Biotechnology AbbVie’s Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures – Cerevel Therapeutics Hldg (NASDAQ:CERE), AbbVie (NYSE:ABBV) Read more
Biotechnology Sarepta Therapeutics’ Next-Gen Duchenne Muscular Therapy Shows Efficacy At Less Frequent Dosing – Sarepta Therapeutics (NASDAQ:SRPT) Read more
Biotechnology Windtree Therapeutics – This Biotech Inks License Deal For Lead Candidate – Windtree Therapeutics (NASDAQ:WINT) Read more
Biotechnology Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutics’ AMPLIFY-201 Phase 1 Solid Tumor Study Of ELI-002 – Elicio Therapeutics (NASDAQ:ELTX) Read more
Biotechnology PTC Therapeutics To Withdraw Its Conditionally Approved Rare Muscle Disorder Disorder Drug In Europe – PTC Therapeutics (NASDAQ:PTCT) Read more
Biotechnology What’s Going On With Panbela Therapeutics Stock? – Panbela Therapeutics (NASDAQ:PBLA) Read more